Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 8 February 2018
Author/s

author: Tanja Kaartinen  Johanna Nystedt  Arno Hänninen  Jukka Partanen 

Publication date February 8, 2018
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item